http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103796643-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-567 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5685 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5685 |
| filingDate | 2012-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103796643-B |
| titleOfInvention | Tablet containing dehydroepiandrosterone (DHEA) |
| abstract | The present invention relates to a kind of tablet with 30-200mg weight, and described tablet contains: the granule of 60-100 weight %, and the dehydroepiandrosterone (DHEA) of consisting of of this granule: 50-90%, with the weighing scale of described granule；The microcrystalline Cellulose of 6-35%, with the weighing scale of described granule；One or more other particulate components pharmaceutically acceptable of 0-20%, with the weighing scale of described granule；And one or more other tablet ingredients pharmaceutically acceptable of 0-40 weight %。These tablets go for the DHEA oral administration of about 50mg dosage, and this tablet is small enough to include in, for instance in the blister package of normal oral contraceptive。 |
| priorityDate | 2011-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 77.